Avioq’s VioOne HIV Profile Supplemental Assay has earned the CE Mark and is seeking distribution partners for Europe.

The enzyme-linked immunosorbent assay (ELISA) confirms and distinguishes between individual antibodies directed to various gene products of HIV-1 and HIV-2 in human serum and blood plasma.

The test is specifically used to confirm the presence of HIV-1 or HIV-2 antibodies in specimens that were repeatedly reactive during diagnostic screening procedures.